TAXUS Performance Superior To Cypher In Diabetic Patients In Head-to-head Study

Sun, 29 Oct 2006 01:00 PM EST

... Boston Scientific Corporation (NYSE: BSX) has announced one-year results from its TC-WYRE (TAXUSâ„¢ Express(2)â„¢ Stent vs. Cypherâ„¢ Stent: What'sYour Real-World Experience?) study, which showed the TAXUS Express(2) paclitaxel-eluting coronary stent to be superior to the Cypher sirolimus-eluting coronary stent in diabetic patients in a head-to-head study. [click link for full article] ...